How many insider trades does FilingIQ track for CGTX?

FilingIQ tracks 152 Form 4 insider transactions for CGTX (COGNITION THERAPEUTICS INC), covering filings from Oct 13, 2021 onwards. 7 of those were filed in the last 90 days.

Are CGTX insiders net buyers or net sellers?

Across the full Form 4 history for CGTX, 35 transactions (23%) were open-market purchases and 5 (3%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.

Where does CGTX insider data come from?

Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ parses the raw XML, normalises insider identity across reporting variations, and scores each trade on its multi-factor composite model.

What sector is CGTX in?

COGNITION THERAPEUTICS INC (CGTX) is classified in the Healthcare sector, specifically Biotechnology, with a current market capitalisation of $98.87M.

CGTX insider trading

Healthcare

COGNITION THERAPEUTICS INC — scored insider trade history from SEC Form 4 filings, parsed and contextualised by FilingIQ.

Total Form 4 trades

152

Last 90 days

Buys / sells

23% / 3%

Market cap

$98.87M

About COGNITION THERAPEUTICS INC

Cognition Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the discovery and development of small molecule therapeutics targeting age-related degenerative diseases and disorders of the central nervous system and retina. Its lead product candidate is CT1812, an orally delivered molecule modulator designed to penetrate the blood-brain barrier and bind selectively to the S2R complex, which is in Phase 2 clinical trial for the treatment of Alzheimer's disease, as well as geographic atrophy secondary to dry age-related macular degeneration and synucleinopathies, such as dementia with Lewy bodies. Cognition Therapeutics, Inc. was incorporated in 2007 and is based in Purchase, New York.

Company website: www.cogrx.com

CGTX insider activity at a glance

FilingIQ has scored 152 insider transactions for CGTX since Oct 13, 2021. The most recent filing in our index is dated May 1, 2026.

Across the full history, 35 open-market purchases and 5 open-market sales were filed under transaction codes P and S respectively. Compensatory share awards (code A) and option exercises (code M) are tracked separately and not counted here.

The average FilingIQ composite score on CGTX insider trades is 50.9/100, produced by FilingIQ's multi-factor Form 4 model. Model framework documented at methodology.

View live CGTX trades on FilingIQ Raw filings on SEC EDGAR

Other Healthcare tickers with recent insider activity

UTHR 1,098

UNITED THERAPEUTICS Corp

APLS 279

Apellis Pharmaceuticals, Inc.

KMDA 218

KAMADA LTD

BMY 185

BRISTOL MYERS SQUIBB CO

ADPT 184

Adaptive Biotechnologies Corp

GH 169

Guardant Health, Inc.

ISRG 166

INTUITIVE SURGICAL INC

VTRS 165

Viatris Inc

Frequently asked

How many insider trades does FilingIQ track for CGTX?: FilingIQ tracks 152 Form 4 insider transactions for CGTX (COGNITION THERAPEUTICS INC), covering filings from Oct 13, 2021 onwards. 7 of those were filed in the last 90 days.
Are CGTX insiders net buyers or net sellers?: Across the full Form 4 history for CGTX, 35 transactions (23%) were open-market purchases and 5 (3%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.
Where does CGTX insider data come from?: Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ parses the raw XML, normalises insider identity across reporting variations, and scores each trade on its multi-factor composite model.
What sector is CGTX in?: COGNITION THERAPEUTICS INC (CGTX) is classified in the Healthcare sector, specifically Biotechnology, with a current market capitalisation of $98.87M.

Methodology & sources

Every CGTX insider transaction shown on FilingIQ is parsed directly from a public SEC Form 4 XML filing. Insider identity is normalised across reporting variants (CIK changes, name spellings, related-party indirect holdings). The FilingIQ composite score is documented in full on the team page and algo disclosure. Not investment advice; see disclaimer.